Nuclear Factor-ĸB- and Glucocorticoid Receptor α- Mediated Mechanisms in the Regulation of Systemic and Pulmonary Inflammation during Sepsis and Acute Respiratory Distress Syndrome
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
To test the hypothesis that the interaction between nuclear factor-ĸB (NF-ĸB) and glucocorticoid receptor α (GRα) is a key pathogenetic mechanism regulating the progression of systemic and pulmonary inflammation in sepsis and acute respiratory distress syndrome (ARDS), we used an ex vivo model of systemic inflammation. Naïve peripheral blood leukocytes (PBL) were exposed to longitudinal (days 1–10) plasma samples from ARDS patients divided into three groups based on physiological improvement and clinical outcome by days 7–10: improvers, nonimprovers-survivors, and nonimprovers-nonsurvivors. In a separate group of nonimprovers-survivors, we correlated the severity of lung histopathology with the intensity of NF-ĸB and GRα nuclear staining in immunohistochemistry analysis of lung tissue obtained by open lung biopsy. We found that exposure of naïve cells to longitudinal plasma samples led to divergent directions in NF-ĸB and GRα activation that reflected the severity of systemic inflammation. Plasma samples from improvers with declining cytokine levels over time elicited a progressive increase in all measured aspects of glucocorticoid (GC)-induced GRα-mediated activity (p = 0.0001) and a correspondent reduction in NF-ĸB nuclear binding (p = 0.0001) and transcription of TNF-α and IL-1β (regulated, GR α-driven response). In contrast, plasma samples from nonimprovers with sustained elevation in cytokine levels over time elicited only a modest longitudinal increase in GC-GRα-mediated activity (p = 0.04) and a progressive increase in NF-ĸB nuclear binding over time (p = 0.0001) that was most striking in nonsurvivors (dysregulated, NF-ĸ B-driven response). By days 3–5, no overlap was observed between groups for NF-ĸB and GC-GRα nuclear binding. In immunohistochemistry analyses, lung tissues of patients with severe versus mild ARDS had a higher intensity of NF-ĸB nuclear staining (13 ± 1.3 vs. 7 ± 2.9; p = 0.01) and a lower ratio of GRα:NF-ĸB in nuclear staining (0.5 ± 0.2 vs. 1.5 ± 0.2; p = 0.007). In conclusion, we demonstrated that the ability of GC-GRα to downregulate NF-ĸB activation is critical for the resolution of systemic and pulmonary inflammation in ARDS. The findings provide a rationale for the use of prolonged GC treatment in early ARDS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overwhelming systemic inflammation that characterizes critical illness is partly driven by an imbalance between hyperactivated inflammatory pathways such as the classical nuclear factor-kappa B (NF-kB) signaling system [6] and the less activated or dysregulated HPAaxis response [7].”
In the citing paper
“Clinical studies in patients with septic shock [79,80] and ARDS [7] have provided evidence of an association between the degree of intracellular glucocorticoid resistance, disease severity, and mortality.”
In the citing paper
“Critical illness is associated with reduced GR-α density and transcription [7,25,82,83]”
In the citing paper
“In experimental ARDS, low-dose glucocorticoid treatment compared with placebo restored GRα number and function with resolution of pulmonary inflammation [7].”
In the citing paper
“In contrast, plasma samples from patients with sustained elevation in inflammatory cytokine levels elicited only modest longitudinal increases in GC-GRα-mediated activity and a progressive increase in NF-kB nuclear binding over time that was most striking in non-survivors (suggesting a dysregulated, NF-kB-driven response).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083 · cited 1×
“The physiologic function of increases in ACTH and GC levels is to suppress inflammation [”
BackgroundBaeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
An Expanded Definition of the Adult Respiratory Distress Syndrome
Murray, J. F., Matthay, M. A., Luce, J. M., & Flick, M. R. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.720 · Cited by 2,646
Research works printed but not linked: 4
- 10.1210%2Fer.17.3.245 · DOI · Paper page
- 10.1210%2Fme.12.3.355 · DOI
- 10.1378%2Fchest.100.6.1619 · DOI · Paper page
- 10.1016%2FS0065-2776%2808%2960742-7 · DOI · Paper page
Cited by
Items 101–167 of 167
Meduri, G. U. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101426 · Cited by 11
Self-citationUmberger, R. A., Thompson, C. L., Cashion, A. K., Kuhl, D. A., Wan, J. Y., Yates, C. R., Muthiah, M. P., & Meduri, G. U. (2015) · Dimensions of Critical Care Nursing · doi:10.1097/dcc.0000000000000098 · Cited by 7
Self-citationVitamin C, Thiamine, and Steroids in the Sepsis Conquest: Replete to Defeat
Guirguis, E. H., Grace, Y., Maarsingh, H., Tran, T. C., & Tkachuk, E. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019851923 · Cited by 8
Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles
Meduri, G. U., Confalonieri, M., Chaudhuri, D., Rochwerg, B. N., & Meibohm, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817558-3.00019-6 · Cited by 11
Self-citationYu, S., Choi, M., Ryoo, S., Cheong, C., Huh, K., Yoon, Y. K., & Jeong, S. J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294872 · Cited by 6
Adjunctive therapies in severe sepsis and septic shock: Current place of steroids
Keh, D., Weber‐Carstens, S., & Ahlers, O. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0058-z · Cited by 6
Marik, P. E., Pastores, S. M., & Annane, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmc066215 · Cited by 6
Cheng, X., Fu, Z., Liu, Y., Zheng, X., & Hu, T. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1190758 · Cited by 11
Soncini, R., Vieira, J., Lopes, A. C. R., Ruginsk, S. G., Incerpi, E. K., & Barchuk, A. R. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.03.001 · Cited by 6
Wildi, K. S., Livingstone, S., Ainola, C., Colombo, S. M., Heinsar, S., Sato, N., Sato, K., Bouquet, M., Wilson, E., Abbate, G., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45081-8 · Cited by 5
Meduri, G. U. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2691-6148 · Cited by 8
Self-citationMohamed, M. B., Hamed, G., Heikal, A., & Darwish, H. M. (2011) · Cited by 4
Treatment mechanism of immune triad from the repurposing drug against COVID-19
Lee, J. (2023) · Translational Medicine of Aging · doi:10.1016/j.tma.2023.06.005 · Cited by 6
Endocrinology of the Stress Response during Critical Illness
Marik, P. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4252-5.50143-x · Cited by 5
Meduri, G. U. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101451 · Cited by 4
Self-citationWildi, K. S., Colombo, S. M., McGuire, D., Ainola, C., Heinsar, S., Sato, N., Sato, K., Liu, K., Bouquet, M., Wilson, E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52698-w · Cited by 3
Meduri, G. U. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2691-6206 · Cited by 3
Self-citationKortikosteroidgabe beim schweren akuten Lungenversagen: Sinnvolle Therapieoption?
Möhnle, P., & Briegel, J. (2012) · Der Anaesthesist · doi:10.1007/s00101-012-1996-2 · Cited by 3
Marik, P. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-11020-2_39 · Cited by 3
Potential of proteasome inhibitors to inhibit cytokine storm in critical stage COVID-19 patientsPreprint
Kircheis, R., Haasbach, E., Lueftenegger, D., Heyken, W. T., Ocker, M., & Planz, O. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2008.10404 · Cited by 3
Immunonutrition in the Critically Ill
Marik, P. E. (2012) · ImmunoGastroenterology · doi:10.7178/ig.1.1.4 · Cited by 2
Fat Embolism Syndrome Treated with Methylprednisolone
Baba, D., Yamashita, Y., Fukuda, Y., Yamaji, K., Shiomi, H., Horie, T., Watanabe, S., & Ono, K. (2024) · Internal Medicine · doi:10.2169/internalmedicine.4472-24 · Cited by 2
Steroids in fibroproliferative acute respiratory distress syndrome: approach with care
Ewanchuk, M., & Jacka, M. J. (2007) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03026873 · Cited by 2
Sabourdin, N. (2015) · Current anesthesiology reports · doi:10.1007/s40140-014-0093-2 · Cited by 2
Mer, M., Schultz, M. J., Adhikari, N. K. J., Kwizera, A., Mohanty, S., Dondorp, A. M., Neto, A. S., & Preller, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-03143-5_5 · Cited by 4
Plasma cortisol level and its relation to in-hospital mortality in acute kidney injury patients
Yousef, E. A. A. M., Elkannishy, S., Arfa, L., & Mahmoud, R. (2021) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/jesnt.jesnt_4_20 · Cited by 2
Adjunctive Measures for Treating Surgical Infections and Sepsis
Byrnes, M. C., & Beilman, G. J. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.09.001 · Cited by 4
Vélez-Páez, J. L. (2023) · Microbes Infection and Chemotherapy · doi:10.54034/mic.e1976 · Cited by 1
The Neonate With Relative Adrenal Insufficiency and Vasopressor Resistance
Fernandez, E. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53366-9.00030-2 · Cited by 1
Utilidad del empleo de esteroides en la disfunción pulmonar aguda
Gordo-Vidal, F., Herranz, E. C., Martín, M. T. M., & Pérez, J. L. (2009) · Medicina Intensiva · doi:10.1016/s0210-5691(09)72197-7 · Cited by 1
Corticosteroids in ARDS: The Never-Ending Story
Thomas, Z., & Kimborowicz, K. (2007) · Hospital Pharmacy · doi:10.1310/hpj4208-691 · Cited by 1
Medidas complementarias para tratar las infecciones y la sepsis de origen quirúrgico
Byrnes, M. C., & Beilman, G. J. (2009) · Clínicas quirúrgicas de Norteamérica
Glucocorticoid Treatment in Acute Respiratory Distress Syndrome: Friend or Foe?
Pelosi, P. P., & Rocco, P. R. M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77383-4_20
Ramirez, N. D. G., Vélez, A. Q., Uribe, L. L. P., & Quijano, C. A. R. (2013) · IATREIA · doi:10.17533/udea.iatreia.13678
Strategies to improve clinical management of community-acquired pneumonia
Meijvis, S. C. A. (2012) · Utrecht University Repository (Utrecht University)
The Adrenal Response to Critical Illness
Alves, M., Borrat, X., & Annane, D. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-177-6_11
Effect Of Low Dose Hydrocortisone On Duration Of Vasopressor Therapy In Septic Shock
Mahajan, B., Puri, S., Mahajan, R., Whig, J., & Deep, G. (2014) · National journal of integrated research in medicine
Sepsis, Acute Respiratory Distress Syndrome, and Glucocorticoid Resistance
Meduri, G. U. (2007) · Elsevier eBooks · doi:10.1016/b978-012373947-6.00733-9
Self-citationTraitement médicamenteux du syndrome de détresse respiratoire aiguë: quelles perspectives?
Delclaux, C. (2007) · Réanimation · doi:10.1016/j.reaurg.2006.12.005
USO DE METILPREDNISOLONA COMO TRATAMENTO ADJUVANTE DO CHOQUE HIPOVOLÉMICO, DISTRIBUTIVO E SÉPTICO
Neves, P., & Martins, R. (2012)
Masterson, C. H. (2013) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/16476
"Que fisiopatologia justifica a utilização de corticoesreróides no choque séptico?"
Coelho, P. M. D. A. A. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/1czt-9269
Corticosteroid Biology in Critical Illness: Modulatory Mechanisms and Clinical Implications
Williams, M., & Menon, D. K. (2009) · Springer eBooks · doi:10.1007/978-3-540-92276-6_68
The Preterm Neonate with Cardiovascular and Adrenal Insufficiency
Fernandez, E. F., & Cole, C. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2763-0.00014-7
Critical Illness-Related Corticosteroid Insufficiency in the Intensive Care Patient
Saillant, N. N., & Sims, C. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-33341-0_30
Kortikosteroidgabe beim schweren akuten Lungenversagen
Kreuer, S., & Pannen, B. H. J. (2012)
Hoffman, C. J. (2014) · VTechWorks (Virginia Tech)
Straaten, H. M. O., Fujikawa, T., & Zimmerman, J. J. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5402-7
Corticosteroid Therapy for Septic Shock and Pediatric ARDS
Jacobs, L., Wong, H. R., & Menon, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-96499-7_16
Diagnosis and Management of Critical Illness—Related Corticosteroid Insufficiency
Marik, P. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4252-5.50145-3
Pituitary and adrenal response to critical illness
Bendel, S. (2010) · UEF eRepo (University of Eastern Finland)
Endocrine and Metabolic Diseases
Hart, K. A., Goff, J. P., Mcfarlane, D., Breuhaus, B. A., Frank, N., de Laat, M. A., McGowan, C. M., Toribio, R. E., Bauman, D. E., Collier, R. J., et al. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-55445-9.00041-0 · Cited by 3
Systemic corticosteroids in the management of covid-19 ARDS
Keller, F. C., Kočí, V., Řiháková, K., Maláska, J., & Stašek, J. (2021) · Anesteziologie a intenzivní medicína · doi:10.36290/aim.2021.036
Colin, G., Maxime, V., & Annane, D. (2009) · Elsevier eBooks · doi:10.1016/b978-2-8101-0089-7.50030-5
Corticosteroid Biology in Critical Illness: Modulatory Mechanisms and Clinical Implications
Williams, M., & Menon, D. K. (2009) · Springer eBooks · doi:10.1007/978-0-387-92278-2_68
Glucocorticoid Treatment in Acute Respiratory Distress Syndrome: Friend or Foe?
Pelosi, P. P., & Rocco, P. R. M. (2008) · Yearbook of intensive care and emergency medicine · doi:10.1007/978-3-540-77290-3_20
Mejia-Vilet, J. M., Toro-Cisneros, N. D., Caballero-Islas, A. E., Martinez-Rueda, A. J., Hernández-Flores, J., Proaño-Zamudio, J. A., Sacoto-Romo, V. M., Fernández-Camargo, D. A., Comunidad-Bonilla, R. A., Navarro-Gerrard, M. A., et al. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000034
Marino, L. O., Gómez, L. M. G., Barbeiro, D. F., Barbeiro, H. V., Brandao, R. A., Menezes, M. C. S., Bachegda, T. A. S. S., & de Sousa, H. P. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4667597
Wen, T.-Z., Fu, W., Xiao, S., Wang, S., Li, T., Chen, X., Chen, H.-Y., Luo, J., Bian, X., & Yao, X. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155251
Clausen, C. L., Johannsen, T. H., Skakkebæk, N. E., Frederiksen, H. W., Juul, A., & Benfield, T. (2024) · Endocrine Connections · doi:10.1530/ec-24-0093 · Cited by 1
Postoperative Critical Care for Esophageal Surgery
Bayram, E., Ciftci, S., & Çiçek, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-47024-0_14
Kim, J. H. (2025) · Archives of Pediatric Critical Care · doi:10.32990/apcc.2025.00031
Tian, F., Liu, Z., Chen, W., Cui, L., Shan, D., Zhang, H., Chai, S., Liu, G., Fan, L., Li, G., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11776-8
Thomas, S. S., Krishnakripa, K., Abhinand, K., Menon, A. M., Ranjith, G., Sony, S. M., Babu, P., Kumar, G. B., Nair, B. G., Arun, K. B., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15050505 · Cited by 1
The Endocrine Axis and Critical Illness
Kim, S. S., & Saillant, N. N. (2026) · Springer eBooks · doi:10.1007/978-3-032-22660-0_33
18F-Fluorodeoxyglucose PET/CT in Sepsis
Ganapathy, C., Khangembam, B. C., & Kumar, R. (2026) · PET Clinics · doi:10.1016/j.cpet.2026.09.004
Osterbur, K. (2012) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/15969
Metadata
- Authors
- Meduri, G. U., Muthiah, M. P., Carratù, P., Eltorky, M., & Chrousos, G. P.
- Affiliations
- University of Tennessee Health Science Center (US)
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 12
- Issue
- 6
- Pages
- 321-338
- ISSN
- 1021-7401 (ISSN-L)
- 1423-0216
- OpenAlex
- W2012983034
- Cited by
- 167
- References
- 64
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 9 · 2023: 11 · 2022: 4 · 2021: 7 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 7 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 5 · 2012: 12
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- NeuroImmunoModulation (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- NF-κB, glucocorticoid receptor alpha, sepsis, acute respiratory distress syndrome, systemic inflammation, lung inflammation, glucocorticoid resistance, cytokine regulation, TNF-α, IL-1β, peripheral blood leukocytes, plasma exposure, lung histopathology, ARDS mortality, glucocorticoid therapy, transcriptional regulation
- MeSH terms
- Adult, Female, Glucocorticoids, Humans, Inflammation, Leukocytes, Lung, Male, Methylprednisolone, Middle Aged, Receptors, Glucocorticoid, Respiratory Distress Syndrome, Cytokines, NF-kappa B, Sepsis, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.